Androgenetic Alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Participants will be given Topical Procapil 5% solution twice daily for 6 months. Intervention 2: Control group: Participants will be given Topical Minoxidil 5% sol
Sponsors
Combined Military Hospital Quetta
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Clinical diagnosis of AGA score 2-5 on Norwood-Hamilton Classification Age range of 18 - 55 years Patients who haven’t received topical or systemic treatments for AGA within 3 months prior to the study. Patient who gave consent for the study
Exclusion criteria
Exclusion criteria: Those with other causes of hair loss such as fungal infection such as taenia capitis, inflammatory or scarring alopecia, hyper-androgenism or other hormonal disorders Hypersensitive to the medications A history of severe systemic disease (renal, cardiovascular hepatic and lungs) Pregnant or breastfeeding patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total hair density and total number of vellus and terminal hairs. Timepoint: before start of study and after 1,2,3 and 6 months after start of study. Method of measurement: Photographic pictures.;Patient satisfaction score. Timepoint: After 6 months. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any side effect after applying minoxidil or Procapil topically. Timepoint: 1,2,3 and 6 months. Method of measurement: interviewing the patients and clinical examination. | — |
Countries
Pakistan
Contacts
Public ContactNosheen Abbas
Combined Military Hospital Quetta
Outcome results
None listed